SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0000950134-97-009363
Filing Date
1997-12-16
Accepted
1997-12-16 00:00:00
Documents
17
Period of Report
1997-08-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 10-KSB FOR YEAR ENDED AUGUST 31, 1997 10KSB 165258
2 ARTICLES OF AMENDMENT EX-3.8 3457
3 AGREEMENT TO TERMINATE EMPLOYMENT AGREEMENT EX-10.5 13587
4 EMPLOYMENT AGREEMENT EX-10.6 3810
5 PROMISSORY NOTE - 11/22/96 EX-10.15 4090
6 PROMISSORY NOTE - 7/29/97 EX-10.16 3535
7 PROMISSORY NOTE - 8/4/97 EX-10.17 3520
8 PROMISSORY NOTE - 8/18/97 EX-10.18 4086
9 PROMISSORY NOTE - 9/23/97 EX-10.19 4080
10 PROMISSORY NOTE - 10/6/97 EX-10.20 4080
11 PROMISSORY NOTE - 10/8/97 EX-10.21 4120
12 PROMISSORY NOTE - 10/21/97 EX-10.22 4094
13 PROMISSORY NOTE - 11/4/97 EX-10.23 4093
14 PROMISSORY NOTE - 11/18/97 EX-10.24 4118
15 PROMISSORY NOTE - 11/19/97 EX-10.25 4034
16 LIST OF SUBSIDIARIES EX-21 261
17 FINANCIAL DATA SCHEDULE EX-27 2055
  Complete submission text file 0000950134-97-009363.txt   235516
Mailing Address 1313 WASHINGTON AVENUE GOLDEN CO 80401
Business Address 1313 WASHINGTON AVE GOLDEN CO 80401 3032799375
GOLDEN PHARMACEUTICALS INC (Filer) CIK: 0000312651 (see all company filings)

IRS No.: 840645174 | State of Incorp.: CO | Fiscal Year End: 0831
Type: 10KSB | Act: 34 | File No.: 000-09065 | Film No.: 97739400
SIC: 2835 In Vitro & In Vivo Diagnostic Substances